eRegister's captcha

Patent Register Details

Print page icon Print this page

PATENT REGISTER
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 1997/012 1999/002 2010/016
Status Expired Patent No. 71155
Application No. 1991/0548 Date of Filing 18/02/1991
Sealing Date 07/01/1997 Application Published 19/08/1991
Title of Invention Acyl compounds
Priority
Priority Country Filing Date Application No.
 Switzerland  19/02/1990  518/90-2
 Switzerland  05/07/1990  2234/90-9
Inventors Peter Buhlmayer
Franz Ostermayer
Tibur Schmidlin
Patent Granted to CIBA-GEIGY AG
Klybeckstrasse 141
CH-4002 Basel
SWITZERLAND
Current Proprietor NOVARTIS AG
Lichtstrasse 35
4002 Basel
SWITZERLAND
Address for service FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39
IRELAND
Renewal Fees
Year Date Renewed
 20  17/02/2010
 19  16/02/2009
 18  18/02/2008
 17  13/02/2007
 16  09/11/2005
 15  07/01/2005
 14  21/01/2004
 13  24/01/2003
 12  22/01/2002
 11  08/01/2001
 10  18/01/2000
 9  21/01/1999
 8  08/01/1998
 7  07/01/1997
 6  07/01/1997
 5  07/01/1997
 4  07/01/1997
 3  07/01/1997
10/07/1997 Request for grant of a Supplementary Protection Certificate, citing Patent number 71155 as the relevent basic patent, in respect of the product Valsartan or a pharmaceutically acceptable salt or ester thereof filed on 26 JUN 1997. Reference number of request is SPC970012.
27/01/1998 NOVARTIS AG, a Swiss Company, of Schwarzwaldallee 215, 4058 Basel, Switzerland, recorded as proprietor by virtue of Certificate of Merger dated 20 DEC 1996. See file no. 70519 for Certificate of Merger.
14/01/1999 Supplementary Protection Certificate Number SPC 12/97, having an expiry date of 12 May 2011, granted on 14 January 1999.
08/03/1999 Request for grant of a Supplementary Protection Certificate, citing Patent number 71155 as the relevent basic patent, in respect of the product Valsartan or a pharmaceutically acceptable salt or ester thereof in combination with hydrochlorothiazide filed on 26 FEB 1999. Reference number of request is SPC990002.
13/03/2006 Request for grant of Supplementary Protection Certificate No. 1999/002 rejected in respect of Article 10(2) of Council Regulation (EEC) No. 1768/92. [Journal No. 2043, 05/04/2006]
20/12/2007 Appeal by Novartis against the rejection of Supplementary Protection Certificate application dismissed by the High Court.
23/04/2008 Change of address of proprietor from NOVARTIS AG, an Aktiengesellschaft organised and existing under the laws of Switzerland, Schwarzwaldallee 215, 4058 Basel, CH to NOVARTIS AG, Lichtstrasse 35, 4002 Basel, CH recorded on 22/04/2008.
25/04/2008 By virtue of a Licence dated 18/04/2008, Novartis Ireland Limited, Beach House, Beach Hill Office Campus, Clonskeagh, Dublin 4, IE, have been registered as exclusive licensee. Certified copy of Licence on File No. 71155.
29/04/2010 Request for grant a Supplementary Protection Certificate, citing Patent number 71155 as the relevant basic patent, in respect of the product Valsartan, amlodipine and hydrochlorithiazide and pharmaceutically acceptable salt thereof filed on 14/04/2010. Reference number of request is 2010/016.
01/11/2010 Application for an extension of the duration of Supplementary Protection Certificate No. 1997/012 filed on 24 September 2010.
30/11/2010 Application for an extension of the duration of Supplementary Protection Certificate No. 1997/012 granted on 22/12/2010. New expiry date of Supplementary Protection Certificate, as extended, is 12/11/2011. [JRNL 2166]
01/03/2011 Patent expired on 17/02/2011.
13/03/2012 Request for grant of Supplementary Protection Certificate No. 2010/016 withdrawn on 13/03/2012. [Journal No. 2200, 11/04/2012]